IIOT-OXYS, Inc.
No enriched coverage for $ITOX in the last 7 days.
No SEC Form 4 filings for $ITOX in the last 30 days.
See all $ITOX insider activity →IIOT-OXYS, Inc. (ITOX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 iiot_ex1001.htm AMENDMENT NO. 2 TO THE SECURITIES PURCHASE AGREEMENT WITH GHS INVESTMENTS Exhibit 10.1 AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 2 to Securities Purchase Agreement (this “ Amendment No. 2 ”), dated effective August 6, 2026 (the
IIOT-OXYS, Inc. (ITOX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. IIOT-OXYS, Inc. 8-K false 0001290658 0001290658 2026-06-16 2026-06-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of
The filing discloses an incremental private financing tranche that can affect near-term dilution expectations and cash runway.
The 8-K discloses a fresh tranche of dilutive convertible preferred financing under an amended SPA, which can pressure equity valuation and affect near-term capital structure expectations.
alphai scores every news story that mentions ITOX with an AI model for sentiment and relevance, and aggregates insider trades from IIOT-OXYS, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
IIOT-OXYS, Inc. (ITOX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 iiot_ex1001.htm AMENDMENT NO. 2 TO THE SECURITIES PURCHASE AGREEMENT WITH GHS INVESTMENTS Exhibit 10.1 AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 2 to Securities Purchase Agreement (this “ Amendment No. 2 ”), dated effective August 6, 2026 (the
4 min readIIOT-OXYS, Inc. (ITOX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. IIOT-OXYS, Inc. 8-K false 0001290658 0001290658 2026-06-16 2026-06-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of
4 min read